FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11179111000001109: Caramet 50mg/200mg CR tablets (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40397101000001113 Caramet 50mg/200mg CR tablets (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
40397201000001118 Caramet 50mg/200mg CR tablets (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Is a Co-careldopa 50mg/200mg modified-release tablets true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Is a Carbidopa + levodopa 50mg/200mg m/r tablet false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has active ingredient Carbidopa true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has active ingredient Levodopa true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Is a Caramet CR true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Is a Co-careldopa 50mg/200mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Is pack of False Caramet 50mg/200mg CR tablets (Teva UK Ltd) Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has AMP True Caramet 50mg/200mg CR tablets (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start